已收盤 07-07 16:00:00 美东时间
0.000
0.00%
Shares of Ironwood Pharmaceuticals (IRWD) added ~4% in the premarket on Tuesday after the company agreed to settle a lawsuit filed by its Swiss partner, Ferring International Center S.A., in October. ...
2025-12-23 20:52
Ironwood Pharma ( ($IRWD) ) has issued an update. On December 18, 2025, Ironwoo...
2025-12-23 20:28
Ironwood Pharmaceuticals' SBS-IF treatment Apraglutide's Phase 3 trial met primary endpoints, reducing PS dependency by 25.5% vs. placebo, but misses on two key secondary endpoints.
2024-03-01 00:34
Ironwood Pharmaceuticals Expects FY23 Addjusted EBITDA Of ~$(900)M, Reflects ~$1.1 billion one-time charge from acquisition of VectivBio
2024-01-08 19:05
Prior 2023 Guidance Updated 2023 Guidance U.S. LINZESS Net Sales Growth 3% to 5% 6% to 8% Total
2023-08-08 19:22
Credit Suisse analyst Tiago Fauth downgrades VectivBio Holding (NASDAQ:VECT) from Outperform to Neutral and lowers the price target from $22 to $17.
2023-05-23 16:23
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has agreed to acquire VectivBio Holding AG (NASDAQ: VECT) for $17.00 per share in an all-cash transaction with an estimated aggregate consideration of approxima
2023-05-23 02:06
NEW YORK, May 22, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2023-05-23 01:23
VectivBio Holding AG (NASDAQ: VECT) shares are trading higher Monday after GI-focused healthcare company Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) agreed to
2023-05-22 22:12
U.S. stocks traded mixed this morning, with the Dow Jones trading slightly lower on Monday. Following the market opening Monday, the Dow traded down 0.01% to 33,422.94 while the NASDAQ rose 0.09% to 12,669.27. The S&P 500, also rose, gaining, 0.08% to 4,195.41.
2023-05-22 21:50